These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39155699)

  • 1. Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long-term risk of cardiovascular events and mortality.
    Chen F; He Y; Wang J; Yu L; Gong Q; Chen Y; An Y; He S; Li G; Zhang B
    J Diabetes; 2024 Aug; 16(8):e13598. PubMed ID: 39155699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired glucose tolerance predicts all-cause mortality among older men at high risk for cardiovascular disease in China.
    Fang F; Wang N; Yan S; Wang L; Lu Y; Li J; Li H; Pham G; Li C; Leng SX; Tian H
    Prim Care Diabetes; 2019 Dec; 13(6):495-504. PubMed ID: 30862424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-up.
    Bignotto M; Bianco E; Centofanti L; Russo A; Dei Cas M; Zermiani P; Morano C; Samartin F; Bertolini E; Bifari F; Berra C; Zuin M; Paroni R; Battezzati PM; Folli F
    Am J Physiol Endocrinol Metab; 2024 Oct; 327(4):E498-E511. PubMed ID: 39196799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
    Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
    Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
    Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
    Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study.
    George A; Bhatia RT; Buchanan GL; Whiteside A; Moisey RS; Beer SF; Chattopadhyay S; Sathyapalan T; John J
    PLoS One; 2015; 10(11):e0142045. PubMed ID: 26571120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
    Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
    Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study].
    Shen XX; Wang JP; Chen YY; An YL; Gong QH; Zhang B; Hong J; Shuai Y; Zhao F; Li H; Li GW
    Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):372-376. PubMed ID: 31060146
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between glucose tolerance and mortality among Japanese community-dwelling older adults aged over 75 years: 12-year observation of the Tosa Longitudinal Aging Study.
    Tatsuno M; Wada T; Kato E; Hirayama K; Fujisawa M; Kimura Y; Ishimoto Y; Hirosaki M; Nose M; Yamada C; Kohori-Segawa H; Kasahara Y; Yamamoto N; Okumiya K; Matsubayashi K; Sakamoto R
    Geriatr Gerontol Int; 2023 May; 23(5):341-347. PubMed ID: 36992614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.
    Nóvoa FJ; Boronat M; Saavedra P; Díaz-Cremades JM; Varillas VF; La Roche F; Alberiche MP; Carrillo A
    Diabetes Care; 2005 Oct; 28(10):2388-93. PubMed ID: 16186268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of metabolic syndrome in midlife in relation to cardiovascular morbidity and all-cause mortality-lessons from a population-based matched cohort study with 27 years follow-up.
    Lönnberg L; Leppert J; Ohrvik J; Rehn M; Chabok A; Damberg M
    BMJ Open; 2024 Sep; 14(9):e081444. PubMed ID: 39284695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.
    Qian X; Wang J; Gong Q; An Y; Feng X; He S; Chen X; Wang W; Zhang L; Hui Y; Zhai X; Zhang B; Chen Y; Li G
    PLoS Med; 2024 Jul; 21(7):e1004419. PubMed ID: 38980837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.
    Bergman M; Chetrit A; Roth J; Dankner R
    Diabetes Metab Res Rev; 2015 May; 31(4):368-75. PubMed ID: 25352076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.